XML 29 R13.htm IDEA: XBRL DOCUMENT v3.20.2
RESTRUCTURING AND ASSET RELATED CHARGES - NET (Notes)
6 Months Ended
Jun. 30, 2020
Restructuring and Related Activities [Abstract]  
Restructuring and Related Activities Disclosure [Text Block] RESTRUCTURING AND ASSET RELATED CHARGES - NET
Charges for restructuring programs and asset related charges, which include other asset impairments, were $19 million and $423 million for the three and six months ended June 30, 2020 ($137 million and $208 million for the three and six months ended June 30, 2019). These charges were recorded in "Restructuring and asset related charges - net" in the interim Consolidated Statements of Operations. The total liability related to restructuring programs was $164 million at June 30, 2020 ($162 million at December 31, 2019). Restructuring activity consists of the following:

2020 Restructuring Program
In the first quarter of 2020, the Company approved restructuring actions designed to capture near-term cost reductions and to further simplify certain organizational structures in anticipation of the expected closure of the Intended N&B Transaction (the "2020 Restructuring Program").

The following tables summarize the charges related to the 2020 Restructuring Program for the three and six months ended June 30, 2020:
 
Three Months Ended June 30, 2020
Six Months Ended June 30, 2020
In millions
Severance and related benefit costs
$
6

$
102

Asset related charges
9

24

Total restructuring and asset related charges - net
$
15

$
126



2020 Restructuring Program Charges (Credits) by Segment
Three Months Ended June 30, 2020
Six Months Ended June 30, 2020
In millions
Electronics & Imaging
$

$
4

Nutrition & Biosciences
1

7

Transportation & Industrial
(3
)
21

Safety & Construction
2

22

Non-Core


Corporate 
15

72

Total
$
15

$
126



The following table summarizes the activities related to the 2020 Restructuring Program:
2020 Restructuring Program
Severance and Related Benefit Costs
Asset Related Charges
Total
In millions
Year-to-date restructuring charges
$
102

$
24

$
126

Charges against the reserve

(24
)
(24
)
Cash payments
(21
)

(21
)
Reserve balance at June 30, 2020
$
81

$

$
81



At June 30, 2020, total liabilities related to the 2020 Restructuring Program were $81 million, recognized in "Accrued and other current liabilities" in the interim Condensed Consolidated Balance Sheets. The Company expects actions related to this program to be substantially complete by the end of 2020.

2019 Restructuring Program
During the second quarter of 2019 and in connection with the ongoing integration activities, DuPont approved restructuring actions to simplify and optimize certain organizational structures following the completion of the Distributions (the "2019 Restructuring Program"). The Company has recorded pre-tax restructuring charges of $140 million inception-to-date, consisting of severance and related benefit costs of $106 million and asset related charges of $34 million.

The following table summarizes the charges incurred related to the 2019 Restructuring Program for the three and six months ended June 30, 2020 and 2019:
 
Three Months Ended June 30,
Six Months Ended June 30,
In millions
2020
2019
2020
2019
Severance and related benefit (credits) costs
$
(16
)
$
50

$
2

$
50

Asset related charges

3


3

Total restructuring and asset related (credits) charges - net
$
(16
)
$
53

$
2

$
53



2019 Restructuring Program (Credits) Charges by Segment
Three Months Ended June 30,
Six Months Ended June 30,
In millions
2020
2019
2020
2019
Electronics & Imaging
$
(3
)
$
7

$
(3
)
$
7

Nutrition & Biosciences
(3
)
14

(3
)
14

Transportation & Industrial
(8
)
12

(7
)
12

Safety & Construction
(14
)
17

(14
)
17

Non-Core




Corporate 
12

3

29

3

Total
$
(16
)
$
53

$
2

$
53



The following table summarizes the activities related to the 2019 Restructuring Program:
2019 Restructuring Program
Severance and Related Benefit Costs
In millions
Reserve balance at December 31, 2019
$
86

Year-to-date restructuring charges
2

Non-cash compensation
(6
)
Cash payments
(40
)
Reserve balance at June 30, 2020
$
42



At June 30, 2020, total liabilities related to the 2019 Restructuring Program were $42 million, recognized in "Accrued and other current liabilities" ($86 million at December 31, 2019) in the interim Condensed Consolidated Balance Sheets. The 2019 Restructuring Program is considered substantially complete at June 30, 2020.

DowDuPont Cost Synergy Program
In September and November 2017, the Company approved post-merger restructuring actions under the DowDuPont Cost Synergy Program, which was designed to integrate and optimize the organization following the Merger and in preparation for the Distributions. The portions of the charges, costs and expenses attributable to integration and optimization within the Agriculture and Materials Science Divisions are reflected in discontinued operations. The Company has recorded pre-tax restructuring charges attributable to the continuing operations of DuPont of $489 million inception-to-date, consisting of severance and related benefit costs of $213 million, asset related charges of $209 million and contract termination and other charges of $67 million.

The following tables summarize the charges incurred related to the DowDuPont Cost Synergy Program:
 
Three Months Ended June 30,
Six Months Ended June 30,
In millions
2020
2019
2020
2019
Severance and related benefit (credits) costs
$
(2
)
$
6

$
(2
)
$
49

Contract termination and other charges
1


6

16

Asset related charges

16


29

Total restructuring and asset related (credits) charges - net 1
$
(1
)
$
22

$
4

$
94


1. The charge for the three and six months ended June 30, 2019 includes $21 million and $92 million which was recognized in "Restructuring and asset related charges - net" and $1 million and $2 million which was recognized in "Equity in earnings of nonconsolidated affiliates" in the interim Consolidated Statements of Operations.

DowDuPont Cost Synergy Program Charges (Credits) by Segment
Three Months Ended June 30,
Six Months Ended June 30,
In millions
2020
2019
2020
2019
Electronics & Imaging
$

$

$

$

Nutrition & Biosciences

8


35

Transportation & Industrial
1


1


Safety & Construction

3

5

5

Non-Core

1



Corporate 
(2
)
10

(2
)
54

Total
$
(1
)
$
22

$
4

$
94



The following table summarizes the activities related to the DowDuPont Cost Synergy Program:
DowDuPont Cost Synergy Program
Severance and Related Benefit Costs
Contract Termination Charges
Total
In millions
Reserve balance at December 31, 2019
$
74

$
2

$
76

Year-to-date restructuring (credits) charges
(2
)
6

4

Charges against the reserve

(1
)
(1
)
Cash payments
(36
)
(2
)
(38
)
Reserve balance at June 30, 2020
$
36

$
5

$
41


At June 30, 2020, total liabilities related to the DowDuPont Cost Synergy Program were $41 million, recognized in "Accrued and other current liabilities" ($76 million at December 31, 2019) in the interim Condensed Consolidated Balance Sheets. The DowDuPont Cost Synergy Program is considered substantially complete at June 30, 2020.

Asset Impairments
In the second quarter of 2020, the Company recorded a $21 million pre-tax impairment charge related to indefinite-lived intangible assets within the Transportation & Industrial segment. This charge was recorded within “Restructuring and asset related charges - net” in the interim Consolidated Statements of Operations for the three and six months ended June 30, 2020. See Note 11 for further discussion.

The Company reviews and evaluates its long-lived assets for impairment when events and changes in circumstances indicate that the related carrying amount of such assets may not be recoverable and may exceed their fair value. For purposes of determining impairment, assets are grouped at the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities.

In the first quarter of 2020, expectations of proceeds related to certain potential divestitures within the Non-Core segment gave rise to fair value indicators and, thus, triggering events requiring the Company to perform a recoverability assessment related to its biomaterials business unit. The Company performed a long-lived asset impairment test and determined that, based on undiscounted cash flows, the carrying amount of certain long-lived assets was not recoverable. Accordingly, the Company estimated the fair value of these assets using a market approach utilizing Level 3 unobservable inputs. As a result, the Company recognized a $270 million pre-tax impairment charge recorded within “Restructuring and asset related charges - net” in the interim Consolidated Statements of Operations for the six months ended June 30, 2020 with the charge impacting definite-lived intangible assets and property, plant, and equipment.

Equity Method Investment Impairment Related Charges
In preparation for the Corteva Distribution, Historical EID completed the separation of the assets and liabilities related to its specialty products businesses into separate legal entities (the “SP Legal Entities”) and on May 1, 2019, Historical EID distributed the SP Legal Entities to DowDuPont (the “Internal SP Distribution”). The Internal SP Distribution served as a triggering event requiring the Company to perform an impairment analysis related to equity method investments held by the Company as of May 1, 2019. The Company applied the net asset value method under the cost approach to determine the fair value of the equity method investments in the Nutrition & Biosciences segment. Based on updated projections, the Company determined the fair value of the equity method investment was below the carrying value and had no expectation the fair value would recover in the short-term due to the current economic environment. As a result, management concluded the impairment was other-than-temporary and recorded an impairment charge of $63 million in “Restructuring and asset related charges - net” in the interim Consolidated Statements of Operations related to the Nutrition & Biosciences segment for the three and six months ended June 30, 2019.